NEUWAY is pursuing several developments projects of its own (see disease areas). However we are also interested in co-developments as well as partnerships to apply the CNS Drug Delivery Technology to compounds provided by the partner with the goal to facilitate their transport through the blood-brain-barrier. With these partnerships we want to exploit the use of EPCs as a tool for drug delivery to the brain for a broad range of active drug substances.
NEUWAY has a flexible approach to deal structuring and aims to create relationships that maximize the value for both parties.
Please direct any inquiries to:
Dr. Rudi Scherhag
Chief Operating Officer
Phone: +49 (0)228 522798-12